Benzodiazepine use among Americans over 75 increased from 12% in 2020 to about 13% in 2024, even as concerns persist about the drugs’ risks for older adults, The New York Times reported Sept. 5.
A recent study published in Annals of Internal Medicine examined benzodiazepine prescribing trends among older adults. The drugs, which include Valium, Xanax and Ativan, are commonly prescribed for insomnia and anxiety.
Here are four things to know:
1. Among adults over 65, overall benzodiazepine use declined from 14% in 2015 to 11.5% in 2024. However, researchers found the decline has stalled since 2020.
2. Use moved in the opposite direction among adults over 75, increasing from 12% in 2020 to about 13% in 2024.
3. Dispensing through pharmacies in long-term care facilities more than doubled, according to the report.
4. About one-third of benzodiazepine users took the drugs for longer than six months, which increases the likelihood of dependence.
At the Becker's Fall Behavioral Health Summit, taking place November 4–5 in Chicago, behavioral health leaders and executives will explore strategies for expanding access to care, integrating services, addressing workforce challenges and leveraging innovation to improve outcomes across the behavioral health continuum. Apply for complimentary registration now.
